Sekundær amenoré
Sist oppdatert: Sist revidert:
Sist revidert av:Terje Johannessen
- Klein DA, Paradise SL, Reeder RM. Amenorrhea: A Systematic Approach to Diagnosis and Management. Am Fam Physician. 2019 Jul 1;100(1):39-48. PMID: 31259490. PubMed
- Solnik MJ. Assessment of secondary amenorrhoea. BMJ Best Practice, last reviewed 20 Sep 2020. bestpractice.bmj.com
- Practice Committee of American Society for Reproductive Medicine. Current evaluation of amenorrhea. Fertil Steril. 2008;90(5 suppl):S219–S225.
- De Souza MJ, Nattiv A, Joy E, et al.; Expert Panel. 2014 female athlete triad coalition consensus statement on treatment and return to play of the female athlete triad: 1st international conference held in San Francisco, California, May 2012 and 2nd international conference held in Indianapolis, Indiana, May 2013. Br J Sports Med. 2014;48(4):289. PubMed
- Gordon CM, Ackerman KE, Berga SL, et al. Functional hypothalamic amenorrhea: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2017;102(5):1413–1439. PMID: 28368518. PubMed
- Ackerman KE, Singhal V, Baskaran C, et al. Oestrogen replacement improves bone mineral density in oligo-amenorrhoeic athletes: A randomised clinical trial. Br J Sport Med 2018. PMID: 30301734 PubMed
- Singhal V, Ackerman KE, Bose A, et al. Impact of route of estrogen administration on bone turnover markers in oligoamenorrheic athletes and its mediators. J Clin Endocrinol Metab 2018. Doi: 10.1210/jc.2018-02143) DOI
- Kalantaridou S, Naka KK, Papanikolaou E, Kazakos N, Kravariti M, Calis KA, et al. Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. J Clin Endocrinol Metab 2004; 89: 3907-13. PubMed
- Norsk gynekologisk forening. Gjør kloke valg. Publisert 13.06.2019. www.legeforeningen.no
- Norsk kvalitetsforbedring av laboratorieundersøkelser (Noklus). Anbefalte analyser ved utvalgte kliniske problemstillinger. Siden besøkt 28.09.2020 www.noklus.no
- Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med. 2009;360(6):606–614.
- Gordon CM. Clinical practice. Functional hypothalamic amenorrhea. N Engl J Med. 2010;363(4):365–371.
- Kakuno Y, Amino N, Kanoh M, et al. Menstrual disturbances in various thyroid diseases. Endocr J. 2010;57(12):1017–1022.
- Falsetti L, Gambera A, Barbetti L, Specchia C. Long-term follow-up of functional hypothalamic amenorrhea and prognostic factors. J Clin Endocrinol Metab. 2002;87(2):500–505.
- American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 108: polycystic ovary syndrome. Obstet Gynecol. 2009;114(4):936–949.
- Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and sub-fertility. Cochrane Database Syst Rev. 2010;(1):CD003053. Cochrane (DOI)
- Bridger T, MacDonald S, Baltzer F, Rodd C. Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome. Arch Pediatr Adolesc Med. 2006;160(3):241–246.
- Molitch ME. Diagnosis and treatment of pituitary adenomas: a review. JAMA. 2017;317(5):516–524. PMID: 28170483. PubMed
- Welt CK, Chan JL, Bullen J, Murphy R, Smith P, DePaoli AM, et al. Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med 2004; 351: 987-97. New England Journal of Medicine
- Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl JMed. 2009;360(6):606–614. PMID: 19196677. PubMed
- van der Schouw Y, van der Graaf Y, Steyerberg EW, Eijkemans JC, Banga JD. Age at menopause as a risk factor for cardiovascular mortality. Lancet 1996; 347: 714-8. PubMed
- Terje Johannessen, professor i allmennmedisin, Trondheim
Tidligere fagmedarbeidere
- Per Bergsjø, professor emeritus, dr. med., Universitetet i Bergen. Spesialist i kvinnesykdommer og fødselshjelp, forsker ved Nasjonalt folkehelseinstitutt, Oslo